Prevention of fibrillation of ventricles
Contents:
- Description
- a href="javascript:if(confirm(%27medicalmeds.eu/consult_new.php?src_razd=bolezn&src_id=3699&vc_spec=4 \n\nThis file was not retrieved by Teleport Pro, because it is addressed on a path excluded by the site\%27s Robot Exclusion parameters. (Teleport Pro\%27s compliance with this system is optional; see the Project Properties, Netiquette page.) \n\nDo you want to open it from the server?%27))window.location=%27medicalmeds.eu/consult_new.php?src_razd=bolezn&src_id=3699&vc_spec=4%27" tppabs="medicalmeds.eu/consult_new.php?src_razd=bolezn&src_id=3699&vc_spec=4">
Description:
Primary prevention of fibrillation of ventricles consists in impact on diseases and states which are etiological factors, and is similar to prevention of a sudden cardiac death.
Considering high probability of emergence of a recurrence of fibrillation of ventricles and ventricular tachycardia without pulse, treatment of all successfully reanimated patients has to include actions for their secondary prevention.
Actions for their secondary prevention of fibrillation of ventricles are based on careful assessment of all possible risk factors, including data of invasive inspection — coronary angiography (at an ischemic heart disease) and programmable electrocardiostimulation.
Secondary prevention includes active treatment of ischemia and heart failure, purpose of antiarrhytmic drugs, it is desirable under control of data of an electrophysiologic research (EFI) , and implantation of a cardioverter defibrillator.
Implantation of a cardioverter defibrillator gains ground. This method of secondary prevention is given preference at inefficiency of control of risk factors by means of other approaches and first of all at patients with low function of emission of a left ventricle.
The cardioverter defibrillator used for vtoricheny prevention of fibrillation of ventricles